Stocks Health care NUS
NYSE · Health careNU Skin Enterprises, Inc. (NUS)
NU Skin Enterprises, Inc. brought in $1.4B of revenue over the twelve months to June 30, 2026, down 15.4% from a year earlier. It posted a net loss of $216.4M. Operating cash flow minus capital spending left $46M of free cash flow in fiscal 2025. At June 30, 2026 it held $189.6M in cash against $213.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What NU Skin Enterprises, Inc. does
NU Skin Enterprises, Inc. is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on NYSE under the ticker NUS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.5B | $160.2M | $3.18 | $46M |
| 2024 | $1.7B | -$146.6M | -$2.95 | $70.2M |
| 2023 | $2B | $8.6M | $0.17 | $60.1M |
| 2022 | $2.2B | $104.8M | $2.07 | $49M |
| 2021 | $2.7B | $147.3M | $2.86 | $73M |
| 2020 | $2.6B | $191.4M | $3.63 | $315.3M |
Where NUS ranks in Health care
Dividends
It paid out $11.8M in cash dividends, 7% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $11.8M | 7% |
| 2024 | n/a | $11.9M | n/a |
| 2023 | n/a | $77.6M | 903% |
| 2022 | n/a | $77M | 74% |
| 2021 | n/a | $76.3M | 52% |
| 2020 | n/a | $78.4M | 41% |
Latest SEC filings
What NU Skin Enterprises, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 21, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- August 10, 2026
- June 1, 2026
- May 29, 2026
- May 21, 2026
- May 14, 2026Passive stake changed SCHEDULE 13G/A
- May 8, 2026
- May 8, 2026Quarterly report 10-Q · period to March 31, 2026
- May 7, 2026
What is NUS worth? A DCF from its reported cash flow
Insider trades
What the people running NU Skin Enterprises, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 9, 2026 | Woodbury Edwina DDirector | Received as pay | 22 | $106.7 |
Questions about NUS
What does NU Skin Enterprises, Inc. do?
NU Skin Enterprises, Inc. is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on NYSE under the ticker NUS.
Is NU Skin Enterprises, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $216.4M on revenue of $1.4B.
How much revenue does NU Skin Enterprises, Inc. make?
Over the twelve months to June 30, 2026 NU Skin Enterprises, Inc. reported revenue of $1.4B. That is 15.4% less than a year earlier.
When did NU Skin Enterprises, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 10, 2026.
Similar companies
Compare NUS with
Follow NUS
Get an email when NU Skin Enterprises, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow NUS: get an email when it filesWhere the numbers come from
Financial figures are the values NU Skin Enterprises, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.